One Impact Planning, Develop a strategy document for the brand's 1-2 year plan that includes opportunity assessment by conducting rigorous collaborative research on business analytics, competitors, forecast to identify focus areas., Bring together stakeholders from different regions and functions to identify needs, streamline objectives, and finalize key initiatives for a broader play., Localize the tactics and create a plan for guidance throughout the year, tailoring it to specific regions and countries., Activate region/country-specific plans to ensure successful implementation and achievement of objectives. Competitor Launch Assessment and Brand Positioning, Benchmarked gold standard therapy in same class of molecules (chemical entity) timelines through different phases (clinical/LSLV-SAC/JNDA/approval) to develop concrete foundation., Apply sensitivities to the timelines around our asset for infectious disease., Create Launch Model with robust estimations and better anticipation., Scout various publications/SEC filing/Posters at conference to capture competitor messaging/status/gaps and position our asset for competitive edge., Provide information for managing budgets, striving timeline of approval during portfolio investment board meets by better anticipation of POS (through benchmarking). CI Executive Guide for priority late stage asset for renal anemia, Landscape report capturing crucial information and observations based on competitor events: Disease Overview, Competitor asset profile, Deal Structure with partners, Regulatory Status, Evidence Summary of trials, Promotional messaging (SUP vs. NI), Conference outputs, Analyst pulse view., Stay on top of Investor events/press releases/analysts' reports to skim crucial intelligence and capture our CI Observations (value insights for any movement observed)., Collaborate with external partners in designing questionnaire with key questions identified during rigorous tracking and participate in interviews conducted with respondents to ensure appropriate moderation and respondent profile/knowledge., Presenter of all the outputs directly to diverse stakeholder groups and onshore franchise leadership through competitor workshops, commercial working groups and medical teams.